293 related articles for article (PubMed ID: 29980788)
1. Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway.
Li A; Chen P; Leng Y; Kang J
Oncogene; 2018 Nov; 37(45):5952-5966. PubMed ID: 29980788
[TBL] [Abstract][Full Text] [Related]
2. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
[TBL] [Abstract][Full Text] [Related]
3. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
4. A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs.
Cheng F; Lienlaf M; Wang HW; Perez-Villarroel P; Lee C; Woan K; Rock-Klotz J; Sahakian E; Woods D; Pinilla-Ibarz J; Kalin J; Tao J; Hancock W; Kozikowski A; Seto E; Villagra A; Sotomayor EM
J Immunol; 2014 Sep; 193(6):2850-62. PubMed ID: 25108026
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
De Jaeghere EA; Denys HG; De Wever O
Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
[TBL] [Abstract][Full Text] [Related]
6. Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines.
Keremu A; Aimaiti A; Liang Z; Zou X
Cancer Chemother Pharmacol; 2019 Feb; 83(2):255-264. PubMed ID: 30430228
[TBL] [Abstract][Full Text] [Related]
7. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer.
Sun X; Qu Q; Lao Y; Zhang M; Yin X; Zhu H; Wang Y; Yang J; Yi J; Hao M
BMC Cancer; 2019 Dec; 19(1):1180. PubMed ID: 31795965
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
11. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.
Cohen N; Shani O; Raz Y; Sharon Y; Hoffman D; Abramovitz L; Erez N
Oncogene; 2017 Aug; 36(31):4457-4468. PubMed ID: 28368410
[TBL] [Abstract][Full Text] [Related]
12. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
[TBL] [Abstract][Full Text] [Related]
13. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b.
Chen Y; Zeng C; Zhan Y; Wang H; Jiang X; Li W
Oncogene; 2017 Aug; 36(33):4692-4705. PubMed ID: 28394344
[TBL] [Abstract][Full Text] [Related]
14. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8
Wu Q; Liu Z; Gao Z; Luo Y; Li F; Yang C; Wang T; Meng X; Chen H; Li J; Kong Y; Dong C; Sun S; Chen C
Theranostics; 2023; 13(4):1381-1400. PubMed ID: 36923542
[No Abstract] [Full Text] [Related]
15. Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.
Cao Y; Cao W; Qiu Y; Zhou Y; Guo Q; Gao Y; Lu N
Pharmacol Res; 2020 Sep; 159():104981. PubMed ID: 32492489
[TBL] [Abstract][Full Text] [Related]
16. Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
M L; P PV; T K; M P; E S; J P; K V W; C L; F C; S D; M SKS; M M; A K; J PI; A S; E S; J W; E M S; A V
Mol Oncol; 2016 May; 10(5):735-750. PubMed ID: 26775640
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination.
Yasuda T; Koiwa M; Yonemura A; Miyake K; Kariya R; Kubota S; Yokomizo-Nakano T; Yasuda-Yoshihara N; Uchihara T; Itoyama R; Bu L; Fu L; Arima K; Izumi D; Iwagami S; Eto K; Iwatsuki M; Baba Y; Yoshida N; Ohguchi H; Okada S; Matsusaki K; Sashida G; Takahashi A; Tan P; Baba H; Ishimoto T
Cell Rep; 2021 Feb; 34(8):108779. PubMed ID: 33626356
[TBL] [Abstract][Full Text] [Related]
18. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
Allam A; Yakou M; Pang L; Ernst M; Huynh J
Front Immunol; 2021; 12():767939. PubMed ID: 34858425
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma.
Cheng Y; Li H; Deng Y; Tai Y; Zeng K; Zhang Y; Liu W; Zhang Q; Yang Y
Cell Death Dis; 2018 Apr; 9(4):422. PubMed ID: 29556041
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy.
Barrett RL; Puré E
Elife; 2020 Dec; 9():. PubMed ID: 33370234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]